Literature DB >> 17635074

Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review.

Cynthia M Balion1, Parminder S Raina, Hertzel C Gerstein, P Lina Santaguida, Katherine M Morrison, Lynda Booker, Dereck L Hunt.   

Abstract

BACKGROUND: The classifications of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) represent glucose levels above normal, but below the decision threshold for diabetes. We sought to determine what the reproducibility of these classifications was when repeat tests were performed by conducting a systematic review of the literature.
METHODS: All primary studies published in English of any study design were included. Studies were excluded if they did not follow the World Health Organization or American Diabetes Association diagnostic criteria, used whole blood as the specimen type, a glucose meter for analysis, or performed repeat testing greater than 8 weeks apart.
RESULTS: Five papers had reproducibility data for IGT or IFG, two of which where from the same population but sampled differently. The kappa coefficients, indicating agreement between repeat tests that exceeded chance, indicated poor to fair agreement for IGT (0.04, 0.22, 0.38, 0.42) and moderate agreement for IFG (0.44 and 0.56). Similarly, the observed reproducibility was slightly lower for IGT (33%, 44%, 47%, 48%) compared to IFG (51%, 64%). In two studies for which data were available for both IGT and IFG, the average reproducibility was lower (49%) for the prediabetes group compared to the diabetes group (73%) or the normal group (93%).
CONCLUSIONS: Poor reproducibility of IGT and IFG classification suggests caution should be exercised when interpreting a single test result.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635074     DOI: 10.1515/CCLM.2007.505

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  32 in total

1.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.

Authors:  Naveen Rathi; Paul K Whelton; Glenn M Chertow; William C Cushman; Alfred K Cheung; Guo Wei; Robert Boucher; Paul L Kimmel; Adam P Bress; Holly J Kramer; Catreena Al-Marji; Tom Greene; Srinivasan Beddhu
Journal:  Am J Hypertens       Date:  2019-11-15       Impact factor: 2.689

Review 3.  Prediabetes diagnosis and treatment: A review.

Authors:  Nidhi Bansal
Journal:  World J Diabetes       Date:  2015-03-15

Review 4.  Innovative uses of electronic health records and social media for public health surveillance.

Authors:  Emma M Eggleston; Elissa R Weitzman
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

5.  Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

Authors:  Kevin J Scully; Jordan S Sherwood; Kimberly Martin; Melanie Ruazol; Peter Marchetti; Mary Larkin; Hui Zheng; Gregory S Sawicki; Ahmet Uluer; Isabel Neuringer; Lael M Yonker; Leonard Sicilian; Deborah J Wexler; Melissa S Putman
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

6.  A1C for screening and diagnosis of type 2 diabetes in routine clinical practice.

Authors:  Zhong X Lu; Karen Z Walker; Kerin O'Dea; Ken A Sikaris; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

7.  Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.

Authors:  Linda J Andes; Yiling J Cheng; Deborah B Rolka; Edward W Gregg; Giuseppina Imperatore
Journal:  JAMA Pediatr       Date:  2020-02-03       Impact factor: 16.193

Review 8.  Issues in Defining the Burden of Prediabetes Globally.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne; Mohammed K Ali
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

Review 9.  Prediabetes: a high-risk state for diabetes development.

Authors:  Adam G Tabák; Christian Herder; Wolfgang Rathmann; Eric J Brunner; Mika Kivimäki
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

10.  Associations Between Prediabetes, by Three Different Diagnostic Criteria, and Incident CVD Differ in South Asians and Europeans.

Authors:  Sophie V Eastwood; Therese Tillin; Naveed Sattar; Nita G Forouhi; Alun D Hughes; Nish Chaturvedi
Journal:  Diabetes Care       Date:  2015-10-20       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.